Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Sponsored by

Logo 22.07.22.png
Vector circle tech with light blue and lamp bulb on technology b

The CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation

The transformation of IP management within commercial companies is driving the adoption of new practices and technologies to more closely align IP objectives with growth strategies, unlock greater portfolio value, and support strategic decision-making across enterprises.

This research white paper from CAS explores this transformation at the nexus of IP and research and development (R&D), where organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation earlier in the product lifecycle.

Missing critical IP information during R&D can lead to misallocated resources, potential patent entanglements downstream, and delays in commercialisation. The white paper provides valuable insights for R&D and IP managers about these critical topics:

  • Top IP management goals over the next 12 months;

  • Role and use of IP information across organisations;

  • Challenges in using IP information; 

  • State of IP information access and investments; and 

  • Resolving IP information gaps 

Click here to access CAS’s white paper – “Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D”

Click here to access CAS’s content hub on Managing IP

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article